BIT
TCON

BlackRock Institutional Trust’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

BlackRock Institutional Trust’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$65K Hold
66
– – ﹤0.01% 3686
2016
Q3 		$88K Hold
66
– – ﹤0.01% 3710
2016
Q2 		$58K Hold
66
– – ﹤0.01% 3755
2016
Q1 		$93K Hold
66
– – ﹤0.01% 3728
2015
Q4 		$122K Buy
66
+37
+128% +$74K ﹤0.01% 3725
2015
Q3 		$57K Buy
+29
New +$67.8K ﹤0.01% 3796

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock Institutional Trust's TCON Position: Q4 2016 in Review

BlackRock Institutional Trust held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q4 2016 at 66 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.

BlackRock Institutional Trust first reported a position in TCON in Q3 2015 and has held it in 6 quarters since. The position peaked at $122K in Q4 2015. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2016.

  • BlackRock Institutional Trust held 66 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $65K as of Q4 2016.
  • BlackRock Institutional Trust left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2016.
  • TRACON Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3686 holding.
  • BlackRock Institutional Trust first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $122K in Q4 2015.
  • 31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.